Granuloma Annulare in Women: Evaluating the Annular Configuration in the Context of Germline Repair
DOI:
https://doi.org/10.17140/WHOJ-4-127Keywords:
Granuloma annulare; Microtubules; Aneuploidy; PolypharmacyAbstract
Granuloma annulare (GA) can be seen in both genders and all age groups, but is most commonly seen in women between the ages
of 30-60 years. GA has a striking geometric presentation, with near perfect circles and ovals, a central clear zone and a pinwheel
configured peripheral rim. We designed a retrospective case series comparing biometric and pharmaceutical data in middle aged
women with and without GA to ascertain correlates of the disease. Women with GA were heavier and took more drugs. The use of
statins, proton pump inhibitors and serotonin reuptake inhibitors were seen more commonly among the cases but the differences
were not statistically significant. Hormone Replacement Therapy (HRT) was seen more commonly in the control group. We propose that the key features of granuloma annulare (female predominance, annular morphology with central clearing, and abrupt onset in the later reproductive years) may relate to events in the fertility cycle that change with age and could be altered by medications
References
Thornsberry LA, English JC 3rd. Etiology, diagnosis, and thera-peutic management of granuloma annulare: An update. Am J Clin Dermatol. 2013; 14 (4): 279-290. doi: 10.1007/s40257-013-0029-5
Kollipara R, Arora C, Reisz C. The phenotype of hormone-related allergic and autoimmune diseases in the skin: Annular le-sions that lateralize. J Allergy (Cairo). 2012; 2012: 604854. doi: 10.1155/2012/604854
Piette EW, Rosenbach M. Granuloma annulare: Pathogenesis, dis-ease associations and triggers, and therapeutic options. J Am Acad Dermatol. 2016; 75(3): 467-479. doi: 10.1016/j.jaad.2015.03.055
Selmi C, Brunetta E, Raimondo MG, Meroni PL. The X chro-mosome and the sex ratio of autoimmunity. Autoimmun Rev. (2012); 11(6-7): A531-A537. doi: 10.1016/j.autrev.2011.11.024
Hughes GC, Choubey D. Modulation of autoimmune rheumatic diseases by oestrogen and progesterone. Nat Rev Rheumatol. 2014; 10(12): 740-751. doi: 10.1038/nrrheum.2014.144
Munoz-Cruz S, Togno-Pierce C, Morales-Montor J. Non-reproductive effects of sex steroids: Their immunoregula-tory role. Curr Top Med Chem. 2011; 11(13): 1714-1727. doi: 10.2174/156802611796117630
Ghazeeri G, Abdullah L, Abbas O. Immunological differences in women compared with men: Overview and contributing factors. Am J Reprod Immunol. 2011; 66(3): 163-169. doi: 10.1111/j.1600- 0897.2011.01052.x
Rubtsov AV, Rubtsova K, Kappler JW, Marrack P. Genetic and hormonal factors in female-biased autoimmunity. Autoimmun Rev. 2010; 9(7): 494-498. doi: 10.1016/j.autrev.2010.02.008
Nicklas RB. How cells get the right chromosomes. Science. 1997; 275(5300): 632-637. doi: 10.1126/science.275.5300.632
Loncarek J, Kisurina-Evgenieva O, Vinogradova T, et al. The centromere geometry essential for keeping mitosis error free is controlled by spindle forces. Nature. 2007; 450(7170): 745-749. doi: 10.1038/nature06344
Hauf S, Watanabe Y. Kinetochore orientation in mitosis and meiosis. Cell. 2004; 119(3): 317–327. doi: 10.1016/j.cell.2004.10.014
Hirano T. Chromosome cohesion, condensation, and separa-tion. Annu Rev Biochem. 2000; 69: 115-144. doi: 10.1146/annurev. biochem.69.1.115
Di Pietro F, Echard A, Morin X. Regulation of mitotic spindle orientation: An integrated view. EMBO Rep. 2016; 17(8): 1106- 1130. doi: 10.15252/embr.201642292
Stinchcombe JC, Griffiths GM. Communication, the centro-some and the immunological synapse. Philos Trans R Soc Lond B Biol Sci. 2014; 369(1650): 20130463. doi: 10.1098/rstb.2013.0463
Desai A, Mitchison TJ. Microtubule polymerization dynamics. Annu Rev Cell Dev Biol. 1997; 13: 83-117. doi: 10.1146/annurev.cell-bio.13.1.83
Joglekar AP, Kukreja AA. How kinetochore architecture shapes the mechanisms of its function. Curr Biol. 2017; 27(6): R816-R824. doi: 10.1016/j.cub.2017.06.012
Lampson MA, Grishchuk EL. Mechanisms to avoid and cor-rect erroneous kinetochore-microtubule attachments. Biology (Ba-sel). 2017; 6(1): pii: E1. doi: 10.3390/biology6010001
Sarangapani KK, Asbury CL. Catch and release: How do kinet-ochores hook the right microtubules during mitosis?. Trends Genet. 2014; 30(4): 150-159. doi: 10.1016/j.tig.2014.02.004
Ménézo Y, Dale B, Cohen M. DNA damage and repair in hu-Submit your article to this journal | https://openventio.org/submit-manuscript/ 14 Reisz C, et al man oocytes and embryos: A review. Zygote. 2010; 18(4): 357-365. doi: 10.1017/S0967199410000286
Lara-Gonzalez P, Westhorpe FG, Taylor S. The spindle assem-bly checkpoint. Curr Biol. 2012; 22(22): R966-980. doi: 10.1016/j. cub.2012.10.006
Wang RH, Yu H, Deng CX. A requirement for breast-can-cer associated gene 1 (BRCA1) in the spindle checkpoint. Proc Natl Acad Sci U S A. 2004; 101(49): 17108-17113. doi: 10.1073/ pnas.0407585101
Chao HX, Poovey CE, Privette AA, et al. Orchestration of DNA damage checkpoint dynamics across the human cell cycle. Cell Syst. 2017; 5(5): 445-459. doi: 10.1016/j.cels.2017.09.015
Krämer A, Lukas J, Bartek J. Checking out the centrosome. Cell Cycle. 2004; 3(11): 1390-3. doi: 10.4161/cc.3.11.1252
Poenie M, Christian L, Tan S, Sykulev Y. Role of the MTOC in T Cell Effector Functions. In: Schatten H. (eds) The Centrosome. Humana Press, Totowa, NJ. 2012.
Bustos-Morán E, Blas-Rus N, Martín-Cófreces N, Sánchez-Madrid F. Orchestrating lymphocyte polarity in cognate immune cell-cell interactions. Int Rev Cell Mol Biol. 2016; 327: 195-261. doi: 10.1016/bs.ircmb.2016.06.004
Vertii A, Ivshina M, Zimmerman W, Hehnly H, Kant S, Doxsey S. The centrosome undergoes Plk1-independent interphase matu-ration during inflammation and mediates cytokine release. Dev Cell. 2016; 37(4): 377-386. doi: 10.1016/j.devcel.2016.04.023
Dumontet C, Sikic B. Mechanisms of action of and resis-tance to antitubulin agents: Microtubule dynamics, drug transport, and cell death. J Clin Oncol. 1999; 17(3): 1061-1070. doi: 10.1200/ JCO.1999.17.3.1061
De Aguiar Vallim TQ, Tarling EJ, Edwards PA. Pleiotropic roles of bile acids in metabolism. Cell Metab. 2013; 17(5): 657-669. doi: 10.1016/j.cmet.2013.03.013
Lindenthal B, Holleran AL, Aldaghlas TA, et al. Progestins block cholesterol synthesis to produce meiosis-activating sterols. FASEB J. 2001; 15(3): 775-784. doi: 10.1096/fj.00-0214com
Xu C, Li CY, Kong AN. Induction of phase I, II and III drug metabolism/transport by xenobiotics. Arch Pharm Res. 2005; 28(3): 249-68.
Soldin OP, Mattison DR. Sex differences in pharmacokinetics and pharmacodynamics. Clin Pharmacokinet. 2009; 48(3): 143-157. doi: 10.2165/00003088-200948030-00001 Case Series | Volume 4 | Number 1|
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content published in Women's Health (WH) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.
